Joint meeting with Fatty Liver Disease and Multi-System Complications
Hepatobiliary Cancers: Pathobiology and Translational Advances
March 22-24, 2021 | 10:00AM EDT | 2:00PM UTC | 3:00PM CET*
*Program is in development and subject to change
Joint Meetings
Your registration provides you with access to both the “Fatty Liver Disease and Multi-System Complications” and “Hepatobiliary Cancers: Pathobiology and Translational Advances” eSymposia events. Use the link below to explore the joint meeting features, including live plenary sessions, On Demand talks, posters, forums, job postings, 1:1 Connect appointments and more. This joint meeting access is designed to facilitate cross-disciplinary insights and collaborations to drive both fields in exciting new directions!
10:00am
- 11:10am EDT
- March 22, 2021
| Room: Multi Tech Session
Jay D. Horton, MD, Co-Chair, University of Texas Southwestern Medical Center;
Alphonse E. Sirica, PhD, Co-Chair, Virginia Commonwealth University
Track: [Joint Session] Welcoming Remarks and Keynote Session
Monday
10:00am
- 10:35am EDT
- March 22, 2021
| Room: V100 Atticus Kiser
Helen H. Hobbs, MD, University of Texas Southwestern Medical Center
Track: [Joint Session] Welcoming Remarks and Keynote Session
Monday
10:35am
- 11:10am EDT
- March 22, 2021
| Room: V100 Atticus Kiser
Hashem B. El-Serag, MD, Baylor College of Medicine
Track: [Joint Session] Welcoming Remarks and Keynote Session
11:10am
- 01:00pm EDT
- March 22, 2021
| Room: Multi Tech Session
Jay D. Horton, MD, Co-Chair, University of Texas Southwestern Medical Center;
Alphonse E. Sirica, PhD, Co-Chair, Virginia Commonwealth University
Track: [Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
Monday
11:10am
- 11:35am EDT
- March 22, 2021
| Room: V300 Guy Coombes
Lopa Mishra, MD, George Washington University
Track: [Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
Monday
11:55am
- 12:20pm EDT
- March 22, 2021
| Room: V200 Ronney Laws
Maria Rescigno, PhD, Humanitas University
Track: [Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
Monday
12:20pm
- 12:45pm EDT
- March 22, 2021
| Room: V200 Ronney Laws
Daniel A. Heller, PhD, Memorial Sloan Kettering Cancer Center
Track: [Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
Monday
12:45pm
- 01:00pm EDT
- March 22, 2021
| Room: V200 Ronney Laws
Juan R. Sanabria, MD, Marshall University/Case Western Reserve University
Track: [Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
Monday
02:30pm
- 03:30pm EDT
- March 22, 2021
Kendra K. Bence, PhD, Panelist, Pfizer Inc.;
Augusto Villanueva Rodriguez, MD, PhD, Panelist, Icahn School of Medicine at Mount Sinai;
Xin Wei Wang, PhD, Panelist, NCI, National Institutes of Health
Track: Career Roundtable
05:00pm
- 08:10pm EDT
- March 22, 2021
| Room: Multi Tech Session
Lopa Mishra, MD, Co-Chair, George Washington University;
Gregory J. Gores, MD, Co-Chair, Mayo Clinic
Track: Tumor Microenvironment and Hepatobiliary Cancers
Monday
05:00pm
- 05:30pm EDT
- March 22, 2021
| Room: V400 Ryan Reid
Silvia Affo, PhD, Columbia University
Track: Tumor Microenvironment and Hepatobiliary Cancers
Monday
05:30pm
- 06:00pm EDT
- March 22, 2021
| Room: V400 Ryan Reid
Amaia Lujambio, PhD, Icahn School of Medicine at Mount Sinai
Track: Tumor Microenvironment and Hepatobiliary Cancers
Monday
06:00pm
- 06:30pm EDT
- March 22, 2021
| Room: V400 Ryan Reid
Alphonse E. Sirica, PhD, Virginia Commonwealth University
Track: Tumor Microenvironment and Hepatobiliary Cancers
Monday
06:40pm
- 07:10pm EDT
- March 22, 2021
Gregory J. Gores, MD, Mayo Clinic
Track: Tumor Microenvironment and Hepatobiliary Cancers
Monday
07:10pm
- 07:25pm EDT
- March 22, 2021
Yuhua Xue, PhD, University of Pittsburgh
Track: Tumor Microenvironment and Hepatobiliary Cancers
Monday
07:25pm
- 07:40pm EDT
- March 22, 2021
Wen-Xing Ding, PhD, University of Kansas Medical Center
Track: Tumor Microenvironment and Hepatobiliary Cancers
Monday
Short Talk: Requirement of Hippo Signaling Cascade during AXIN1 Mutation Driven Hepatocarcinogenesis
07:40pm
- 07:55pm EDT
- March 22, 2021
Haichuan Wang, University of California, San Francisco
Track: Tumor Microenvironment and Hepatobiliary Cancers
Monday
07:55pm
- 08:10pm EDT
- March 22, 2021
Juan Pablo Unfried, PhD, University of Navarra
Track: Tumor Microenvironment and Hepatobiliary Cancers
10:00am
- 01:10pm EDT
- March 23, 2021
| Room: Multi Tech Session
Gregory J. Gores, MD, Co-Chair, Mayo Clinic;
Alphonse E. Sirica, PhD, Co-Chair, Virginia Commonwealth University
Track: Hepatobiliary Cancer Biomarkers and Molecular Subtypes
Tuesday
10:00am
- 10:30am EDT
- March 23, 2021
| Room: V600 Zach Smith
Yujin Hoshida, MD, PhD, UT Southwestern Medical Center
Track: Hepatobiliary Cancer Biomarkers and Molecular Subtypes
Tuesday
10:30am
- 11:00am EDT
- March 23, 2021
| Room: V600 Zach Smith
Augusto Villanueva Rodriguez, MD, PhD, Icahn School of Medicine at Mount Sinai
Track: Hepatobiliary Cancer Biomarkers and Molecular Subtypes
Tuesday
11:00am
- 11:30am EDT
- March 23, 2021
| Room: V600 Zach Smith
Jessica Zucman-Rossi, MD, PhD, University Paris Descartes-HEGP
Track: Hepatobiliary Cancer Biomarkers and Molecular Subtypes
Tuesday
11:40am
- 12:10pm EDT
- March 23, 2021
| Room: V100 Atticus Kiser
Jesper Bøje Andersen, PhD, University of Copenhagen
Track: Hepatobiliary Cancer Biomarkers and Molecular Subtypes
Tuesday
12:10pm
- 12:40pm EDT
- March 23, 2021
| Room: V100 Atticus Kiser
Robert F. Schwabe, MD, Columbia University
Track: Hepatobiliary Cancer Biomarkers and Molecular Subtypes
Tuesday
12:40pm
- 12:55pm EDT
- March 23, 2021
| Room: V100 Atticus Kiser
Kerstin Seidel, PhD, Genentech
Track: Hepatobiliary Cancer Biomarkers and Molecular Subtypes
Tuesday
12:55pm
- 01:10pm EDT
- March 23, 2021
| Room: V100 Atticus Kiser
Sungjin Ko, PhD, University of Pittsburgh
Track: Hepatobiliary Cancer Biomarkers and Molecular Subtypes
Tuesday
02:30pm
- 03:30pm EDT
- March 23, 2021
Elena Bellafante, Panelist, Med- Cell Press;
Francesco Giovinazzo, Panelist, Frontiers;
Xin (Cindy) Sun, PhD, Panelist, Journal of Experimental Medicine (JEM)
Track: Meet the Editors Roundtable
05:00pm
- 08:10pm EDT
- March 23, 2021
| Room: Multi Tech Session
Lopa Mishra, MD, Co-Chair, George Washington University;
Alphonse E. Sirica, PhD, Co-Chair, Virginia Commonwealth University
Track: Genomics, Molecular Heterogeneity, and Precision Medicine in Hepatobiliary Cancers
Tuesday
05:00pm
- 05:30pm EDT
- March 23, 2021
| Room: V300 Guy Coombes
Irene Oi Lin Ng, MD, PhD, University of Hong Kong
Track: Genomics, Molecular Heterogeneity, and Precision Medicine in Hepatobiliary Cancers
Tuesday
05:30pm
- 06:00pm EDT
- March 23, 2021
| Room: V300 Guy Coombes
Xin Wei Wang, PhD, NCI, National Institutes of Health
Track: Genomics, Molecular Heterogeneity, and Precision Medicine in Hepatobiliary Cancers
Tuesday
06:00pm
- 06:30pm EDT
- March 23, 2021
| Room: V300 Guy Coombes
Renumathy Dhanasekaran, MD, Stanford University
Track: Genomics, Molecular Heterogeneity, and Precision Medicine in Hepatobiliary Cancers
Tuesday
06:40pm
- 07:10pm EDT
- March 23, 2021
| Room: V100 Atticus Kiser
Teh Bin Tean, MD, PhD, Duke-NUS Medical School
Track: Genomics, Molecular Heterogeneity, and Precision Medicine in Hepatobiliary Cancers
Tuesday
07:10pm
- 07:40pm EDT
- March 23, 2021
| Room: V100 Atticus Kiser
Josep Llovet, MD, PhD, Icahn School of Medicine at Mount Sinai
Track: Genomics, Molecular Heterogeneity, and Precision Medicine in Hepatobiliary Cancers
Tuesday
07:40pm
- 07:55pm EDT
- March 23, 2021
| Room: V100 Atticus Kiser
Bangyan L. Stiles, PhD, University of Southern California
Track: Genomics, Molecular Heterogeneity, and Precision Medicine in Hepatobiliary Cancers
Tuesday
07:55pm
- 08:10pm EDT
- March 23, 2021
| Room: V100 Atticus Kiser
Chungui Xu, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
Track: Genomics, Molecular Heterogeneity, and Precision Medicine in Hepatobiliary Cancers
10:00am
- 01:05pm EDT
- March 24, 2021
| Room: Multi Tech Session
Gregory J. Gores, MD, Co-Chair, Mayo Clinic;
Lopa Mishra, MD, Co-Chair, George Washington University
Track: Advances in Molecular and Immune Targeting of Hepatobiliary Cancers
Wednesday
10:00am
- 10:30am EDT
- March 24, 2021
| Room: V300 Guy Coombes
Tim F. Greten, MD, NCI, National Institutes of Health
Track: Advances in Molecular and Immune Targeting of Hepatobiliary Cancers
Wednesday
10:30am
- 11:00am EDT
- March 24, 2021
| Room: V300 Guy Coombes
R. Kate Kelley, MD, University of California, San Francisco
Track: Advances in Molecular and Immune Targeting of Hepatobiliary Cancers
Wednesday
11:00am
- 11:30am EDT
- March 24, 2021
| Room: V300 Guy Coombes
Bruno Sangro, MD, PhD, Clinica Universidad de Navarra
Track: Advances in Molecular and Immune Targeting of Hepatobiliary Cancers
Wednesday
11:40am
- 11:55am EDT
- March 24, 2021
| Room: V100 Atticus Kiser
Miryam Müller, PhD, CRUK Beatson Institute
Track: Advances in Molecular and Immune Targeting of Hepatobiliary Cancers
Wednesday
11:55am
- 12:10pm EDT
- March 24, 2021
| Room: V100 Atticus Kiser
Jonathan M. Hernandez, MD, NCI, National Institutes of Health
Track: Advances in Molecular and Immune Targeting of Hepatobiliary Cancers
Wednesday
12:10pm
- 12:25pm EDT
- March 24, 2021
| Room: V100 Atticus Kiser
Massimiliano Cadamuro, PhD, University of Padua
Track: Advances in Molecular and Immune Targeting of Hepatobiliary Cancers
Wednesday
12:25pm
- 12:40pm EDT
- March 24, 2021
| Room: V100 Atticus Kiser
Man Hsin Hung, MD, PhD, NCI, National Institutes of Health
Track: Advances in Molecular and Immune Targeting of Hepatobiliary Cancers
Wednesday
12:40pm
- 12:55pm EDT
- March 24, 2021
| Room: V100 Atticus Kiser
Andreas Prokesch, PhD, Medical University Graz
Track: Advances in Molecular and Immune Targeting of Hepatobiliary Cancers
Wednesday
12:55pm
- 01:05pm EDT
- March 24, 2021
| Room: V100 Atticus Kiser
Track: Advances in Molecular and Immune Targeting of Hepatobiliary Cancers